Melbourne, Australia, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF), (“Amplia” or the “Company”), is pleased to announce that an additional confirmed partial ...

LONDON - NuCana plc (NASDAQ:NCNA), a micro-cap biotech currently trading at $4.28, presented new clinical data Wednesday for its experimental cancer drug NUC-7738 in combination with pembrolizumab for ...

Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, Vienna 1090, Austria Vienna Doctoral School of Pharmaceutical, Nutritional and Sport Sciences, University of Vienna ...

Competitive enzyme inhibition happens when an inhibitor competes with the substrate to bind to the enzyme’s active site. This type of inhibition is characterized by the competitive inhibitor with a ...

Previous studies had indicated that treatments for the rare condition known as VEXAS were either not very effective or came with major side effects. Interleukin-1 inhibitors are among the treatments ...

Researchers conducted a multicenter observational study across three major US academic medical centers with registries of patients with rheumatic immune-related adverse events to assess the ...

Modern humans are evolutionary survivors, thriving generation after generation while our ancient relatives died out. Now, new research into our brain chemistry suggests that an enzyme unique to Homo ...

MELBOURNE, Australia (AP) — Epic Games, the company behind the popular online game Fortnite, on Tuesday won a partial victory in an Australian court. The case was brought by U.S. billionaire chief ...